<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=457360127799285&amp;ev=PageView&amp;noscript=1">

Therapeutic Areas



Gastrointestinal (GI) clinical trials such as Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome with Constipation (IBS-C), and Irritable Bowel Syndrome with Diahrrea (IBS-D) have been conducted by Chase Medical Research (CMR). 

Some of these clinical trials resulted in FDA approved medications such as Linzess for IBS and Trulance for IBS-C. 

Current Enrolling Studies

Learn more about the clinical trials that we are presently conducting or are about to begin.